249 related articles for article (PubMed ID: 36602988)
1. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.
Xu X; Kumari R; Zhou J; Chen J; Mao B; Wang J; Zheng M; Tu X; An X; Chen X; Zhang L; Tian X; Wang H; Dong X; Bao Z; Guo S; Ouyang X; Shang L; Wang F; Yan X; Zhang R; Vries RGJ; Clevers H; Li QX
PLoS One; 2023; 18(1):e0279821. PubMed ID: 36602988
[TBL] [Abstract][Full Text] [Related]
2. Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research.
Xu X; Shang L; Wang P; Zhou J; Ouyang X; Zheng M; Mao B; Zhang L; Chen B; Wang J; Chen J; Qian W; Guo S; Huang Y; Li QX
J Vis Exp; 2021 May; (171):. PubMed ID: 34028430
[TBL] [Abstract][Full Text] [Related]
3. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
Kumari R; Xu X; Li HQ
Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
[TBL] [Abstract][Full Text] [Related]
4. Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.
Aizawa Y; Takada K; Aoyama J; Sano D; Yamanaka S; Seki M; Kuze Y; Ramilowski JA; Okuda R; Ueno Y; Nojima Y; Inayama Y; Hatakeyama H; Hatano T; Takahashi H; Nishimura G; Fujii S; Suzuki Y; Taniguchi H; Oridate N
Cell Oncol (Dordr); 2023 Apr; 46(2):409-421. PubMed ID: 36538240
[TBL] [Abstract][Full Text] [Related]
5. Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments.
Lago C; Federico A; Leva G; Mack NL; Schwalm B; Ballabio C; Gianesello M; Abballe L; Giovannoni I; Reddel S; Rossi S; Leone N; Carai A; Mastronuzzi A; Bisio A; Soldano A; Quintarelli C; Locatelli F; Kool M; Miele E; Tiberi L
EMBO Mol Med; 2023 Dec; 15(12):e18199. PubMed ID: 38037472
[TBL] [Abstract][Full Text] [Related]
6. Applications of patient-derived tumor xenograft models and tumor organoids.
Yoshida GJ
J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
[TBL] [Abstract][Full Text] [Related]
7. A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.
Beshiri ML; Tice CM; Tran C; Nguyen HM; Sowalsky AG; Agarwal S; Jansson KH; Yang Q; McGowen KM; Yin J; Alilin AN; Karzai FH; Dahut WL; Corey E; Kelly K
Clin Cancer Res; 2018 Sep; 24(17):4332-4345. PubMed ID: 29748182
[No Abstract] [Full Text] [Related]
8. Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer.
Bigot L; Sabio J; Poiraudeau L; Annereau M; Menssouri N; Helissey C; Déas O; Aglave M; Ibrahim T; Pobel C; Nobre C; Nicotra C; Ngo-Camus M; Lacroix L; Rouleau E; Tselikas L; Judde JG; Chauchereau A; Bernard-Tessier A; Patrikidou A; Naoun N; Flippot R; Colomba E; Fuerea A; Albiges L; Lavaud P; Massard C; Friboulet L; Fizazi K; Besse B; Scoazec JY; Loriot Y
Eur Urol Oncol; 2024 Jun; 7(3):527-536. PubMed ID: 38433714
[TBL] [Abstract][Full Text] [Related]
9. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology.
Guillen KP; Fujita M; Butterfield AJ; Scherer SD; Bailey MH; Chu Z; DeRose YS; Zhao L; Cortes-Sanchez E; Yang CH; Toner J; Wang G; Qiao Y; Huang X; Greenland JA; Vahrenkamp JM; Lum DH; Factor RE; Nelson EW; Matsen CB; Poretta JM; Rosenthal R; Beck AC; Buys SS; Vaklavas C; Ward JH; Jensen RL; Jones KB; Li Z; Oesterreich S; Dobrolecki LE; Pathi SS; Woo XY; Berrett KC; Wadsworth ME; Chuang JH; Lewis MT; Marth GT; Gertz J; Varley KE; Welm BE; Welm AL
Nat Cancer; 2022 Feb; 3(2):232-250. PubMed ID: 35221336
[TBL] [Abstract][Full Text] [Related]
10. Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling.
Van Hemelryk A; Tomljanovic I; de Ridder CMA; Stuurman DC; Teubel WJ; Erkens-Schulze S; Verhoef EI; Remmers S; Mahes AJ; van Leenders GJLH; van Royen ME; van de Werken HJG; Grudniewska M; Jenster GW; van Weerden WM
Cells; 2022 Nov; 11(22):. PubMed ID: 36429059
[TBL] [Abstract][Full Text] [Related]
11. The first Japanese biobank of patient-derived pediatric acute lymphoblastic leukemia xenograft models.
Tanaka K; Kato I; Dobashi Y; Imai JI; Mikami T; Kubota H; Ueno H; Ito M; Ogawa S; Nakahata T; Takita J; Toyoda H; Ogawa C; Adachi S; Watanabe S; Goto H
Cancer Sci; 2022 Nov; 113(11):3814-3825. PubMed ID: 35879192
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
Vlachogiannis G; Hedayat S; Vatsiou A; Jamin Y; Fernández-Mateos J; Khan K; Lampis A; Eason K; Huntingford I; Burke R; Rata M; Koh DM; Tunariu N; Collins D; Hulkki-Wilson S; Ragulan C; Spiteri I; Moorcraft SY; Chau I; Rao S; Watkins D; Fotiadis N; Bali M; Darvish-Damavandi M; Lote H; Eltahir Z; Smyth EC; Begum R; Clarke PA; Hahne JC; Dowsett M; de Bono J; Workman P; Sadanandam A; Fassan M; Sansom OJ; Eccles S; Starling N; Braconi C; Sottoriva A; Robinson SP; Cunningham D; Valeri N
Science; 2018 Feb; 359(6378):920-926. PubMed ID: 29472484
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer PDxO cultures for drug discovery and functional precision oncology.
Scherer SD; Zhao L; Butterfield AJ; Yang CH; Cortes-Sanchez E; Guillen KP; Welm BE; Welm AL
STAR Protoc; 2023 Sep; 4(3):102402. PubMed ID: 37402170
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.
Chew NJ; Lim Kam Sian TCC; Nguyen EV; Shin SY; Yang J; Hui MN; Deng N; McLean CA; Welm AL; Lim E; Gregory P; Nottle T; Lang T; Vereker M; Richardson G; Kerr G; Micati D; Jardé T; Abud HE; Lee RS; Swarbrick A; Daly RJ
Breast Cancer Res; 2021 Aug; 23(1):82. PubMed ID: 34344433
[TBL] [Abstract][Full Text] [Related]
16. [Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models].
Pauli C; Moch H; Rubin MA
Pathologe; 2017 Nov; 38(Suppl 2):160-168. PubMed ID: 28956107
[TBL] [Abstract][Full Text] [Related]
17. Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells.
Hou X; Du C; Lu L; Yuan S; Zhan M; You P; Du H
World J Surg Oncol; 2022 Feb; 20(1):37. PubMed ID: 35177071
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening.
Luo Z; Wang B; Luo F; Guo Y; Jiang N; Wei J; Wang X; Tseng Y; Chen J; Zhao B; Liu J
BMC Med; 2023 Sep; 21(1):336. PubMed ID: 37667332
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
[TBL] [Abstract][Full Text] [Related]
20. Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids.
Van Hemelryk A; Erkens-Schulze S; Lim L; de Ridder CMA; Stuurman DC; Jenster GW; van Royen ME; van Weerden WM
Cells; 2023 May; 12(10):. PubMed ID: 37408211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
